Tarasova; Nadya I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tarasova; Nadya I..The latest application filed is for "use of peptide-based inhibitors of the stat3-il10 pathway for treating bacterial infection and granulomatous disease".

Company Profile

1.13.13

Tarasova; Nadya I. - Frederick MD
Tarasova, Nadya I - Frederick MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease Grant 10,512,673 - Tarasova , et al. Dec	2019-12-24
Use Of Peptide-based Inhibitors Of The Stat3-il10 Pathway For Treating Bacterial Infection And Granulomatous Disease App 20180000901 - Tarasova; Nadya I. ; et al.	2018-01-04
Peptide-based Stat Inhibitor App 20170204148 - Tarasova; Nadya I. ; et al.	2017-07-20
Peptide-based stat inhibitor Grant 9,540,427 - Tarasova , et al. January 10, 2	2017-01-10
Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling Grant 9,475,839 - Tarasova , et al. October 25, 2	2016-10-25
Lipopeptide Inhibitors Of Ras Oncoproteins App 20160151456 - Tarasova; Nadya I. ; et al.	2016-06-02
Lipopeptide inhibitors of RAS oncoproteins Grant 9,328,142 - Tarasova , et al. May 3, 2	2016-05-03
Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs Grant 9,326,950 - Tarasova , et al. May 3, 2	2016-05-03
Synthetic peptide inhibitors of Wnt pathway Grant 9,056,891 - Tarasova , et al. June 16, 2	2015-06-16
Lipopeptide Inhibitors Of Ras Oncoproteins App 20140135276 - Tarasova; Nadya I. ; et al.	2014-05-15
Synthetic Peptide Inhibitors Of Wnt Pathway App 20130273058 - Tarasova; Nadya I. ; et al.	2013-10-17
Peptide-based Inhibitor Of Interleukin-10 Or Interferon-gamma Signaling App 20130109619 - Tarasova; Nadya I. ; et al.	2013-05-02
Azonafide derived tumor and cancer targeting compounds Grant 8,008,316 - Tarasova , et al. August 30, 2	2011-08-30
Synthetic Analogs Of The Juxtamembrane Domain Of Igf1r And Uses Thereof App 20110195911 - Tarasova; Nadya I. ; et al.	2011-08-11
Peptide-based Stat Inhibitor App 20100184697 - Tarasova; Nadya I. ; et al.	2010-07-22
Azonafide Derived Tumor And Cancer Targeting Compounds App 20100120817 - Tarasova; Nadya I. ; et al.	2010-05-13
Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs App 20100034896 - Tarasova; Nadya I. ; et al.	2010-02-11
Inhibition of ABC transporters by transmembrane domain analogs Grant 7,517,849 - Tarasova , et al. April 14, 2	2009-04-14
G protein-coupled receptor antagonists Grant 7,105,488 - Tarasova , et al. September 12, 2	2006-09-12
Conjugates of ligand linker and cytotoxic agent and related composition and methods of use App 20050171014 - Tarasova, Nadya I ; et al.	2005-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.